What is the purpose of the new credit facility?

The $125 million unsecured revolving credit facility is primarily for IDEXX's general corporate purposes, which can include funding stock repurchases and pursuing potential acquisitions.

When does the credit facility expire?

The credit facility has a maturity date of June 30, 2007, meaning all outstanding loans must be repaid by this date.

Are there any restrictions or conditions associated with this credit facility?

Yes, the facility is subject to customary covenants, including restrictions on liens, subsidiary indebtedness, fundamental changes, investments, affiliate transactions, and negative pledges. It also includes financial covenants, such as debt-to-EBITDA ratios. Additionally, certain material subsidiaries must provide guarantees for the obligations.

What are the interest rate terms for borrowings under this facility?

For U.S. Dollar and alternative currency borrowings, interest is calculated as the British Bankers Association LIBO rate plus a margin (0.375% to 0.875%) based on the leverage ratio, or the higher of the Federal Funds Rate plus 0.50% and the prime rate. For Canadian Dollar borrowings, it's the CDOR rate plus a margin (0.375% to 0.875%) based on the leverage ratio, or the higher of the one-month CDOR Rate plus 1% or the prime rate.

IDXX 8-K: Material Agreements & Financial Events

Summary

IDEXX LABORATORIES INC (IDXX) announced on January 31, 2007, the execution of a credit agreement establishing a six-month, $125 million unsecured revolving credit facility. This facility, with JPMorgan Chase Bank, National Association, provides flexible financing for general corporate purposes, including stock repurchases and potential acquisitions. The agreement includes provisions for borrowings in both U.S. Dollars and Canadian Dollars, with interest rates tied to LIBOR or CDOR plus a margin, and a commitment fee on unused portions. The credit facility has a maturity date of June 30, 2007, and requires certain material subsidiaries to act as guarantors for the obligations. The agreement also contains customary covenants, including restrictions on debt, liens, and fundamental changes, as well as financial covenants related to debt-to-EBITDA ratios. The company retains the option to use the facility for strategic initiatives, offering flexibility in managing its capital structure and pursuing growth opportunities.

Key Highlights

1Execution of a $125 million unsecured revolving credit facility maturing on June 30, 2007.
2Facility is intended for general corporate purposes, including stock repurchases and acquisitions.
3Includes a Cdn$60 million sublimit for borrowings denominated in Canadian Dollars.
4Interest rates are based on LIBOR/CDOR plus a margin, with options for U.S. Dollar and Canadian Dollar borrowings.
5Requires guarantees from certain material subsidiaries.
6Contains customary affirmative, negative, and financial covenants, including debt-to-EBITDA ratios.
7The credit facility provides financial flexibility for the company's operations and strategic plans.

IDEXX LABORATORIES INC /DE 8-K Report, Material Agreement (Jan 31, 2007)

Summary

Key Highlights

Frequently Asked Questions